Back to Search
Start Over
Stentless bioprostheses: a versatile and durable solution in extensive aortic valve endocarditis.
- Source :
-
European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery [Eur J Cardiothorac Surg] 2016 Jun; Vol. 49 (6), pp. 1699-704. Date of Electronic Publication: 2016 Jan 19. - Publication Year :
- 2016
-
Abstract
- Objectives: Infective endocarditis of the aortic valve with local aortic root destruction requires radical resection of infected tissues and subsequent reconstruction of periannular structures and the left ventricular outflow tract (LVOT). Homografts or stentless bioprostheses are recommended for use in this specific patient group. The Freestyle stentless bioprosthesis is a porcine aortic root prosthesis, which approaches the surgical versatility of the homograft, but has the advantage of ready availability and uniform quality. We assessed clinical and echocardiographic outcome following the use of this prosthesis in extensive aortic valve endocarditis.<br />Methods: Between June 2000 and December 2014, 55 Freestyle prostheses were implanted for aortic valve endocarditis involving the root in 54 patients (74% male). The mean age at operation was 61 ± 13 years. The mean EuroSCORE II was 20.1 ± 13.5. Twenty-nine (54%) patients had prosthetic valve endocarditis. The median follow-up time after surgery was 3.5 years, ranging from 0 to 15 years.<br />Results: Early and late mortality were 11% (6 patients) and 14% (7 patients), respectively. Estimated overall survival at 1 and 5 years was 83 and 70%, respectively. There was no survival difference between patients with native or prosthetic valve endocarditis. One patient underwent reoperation for recurrent endocarditis 2.3 years after the initial procedure. No other prosthesis failure occurred. At a median follow-up of 3.3 years, mean gradient over the prosthesis was 4.3 ± 2.3 mmHg. No patient had more than mild aortic regurgitation.<br />Conclusions: The Freestyle stentless bioprosthesis is a valuable option to reconstruct the LVOT after debridement in extensive aortic valve endocarditis. It is readily available with a versatility and clinical outcome comparable with that of homografts. Although early mortality remains considerable in this high-risk group of patients, late survival is good with low rates of recurrence of endocarditis, immediate local control and good haemodynamic performance on echocardiography.<br /> (© The Author 2016. Published by Oxford University Press on behalf of the European Association for Cardio-Thoracic Surgery. All rights reserved.)
- Subjects :
- Adult
Aged
Aortic Valve microbiology
Echocardiography
Endocarditis, Bacterial diagnostic imaging
Endocarditis, Bacterial microbiology
Female
Follow-Up Studies
Heart Valve Diseases diagnostic imaging
Heart Valve Diseases microbiology
Heart Valve Prosthesis Implantation adverse effects
Heart Valve Prosthesis Implantation methods
Humans
Kaplan-Meier Estimate
Male
Middle Aged
Prosthesis Design
Prosthesis-Related Infections diagnostic imaging
Prosthesis-Related Infections microbiology
Prosthesis-Related Infections surgery
Stents
Aortic Valve surgery
Bioprosthesis adverse effects
Endocarditis, Bacterial surgery
Heart Valve Diseases surgery
Heart Valve Prosthesis adverse effects
Subjects
Details
- Language :
- English
- ISSN :
- 1873-734X
- Volume :
- 49
- Issue :
- 6
- Database :
- MEDLINE
- Journal :
- European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery
- Publication Type :
- Academic Journal
- Accession number :
- 26792920
- Full Text :
- https://doi.org/10.1093/ejcts/ezv463